Figure 3.

Effects of notoginsenoside Ft1 on PT, APTT and TT of human plasma in vitro. Human plasma was incubated with 240 μg·mL−1 of Ft1 or 160 μg·mL−1 of CIH for 5 min followed by plasma coagulation assays. (Compared with control, ***P < 0.001, n = 7, mean ± SD).